Skip to content
DataLookout
Menu

MITOMYONCT07920562

Role of AMPKalpha2 in Myonuclear Accretion in Mitochondrial Myopathies

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Metabolic dysfunction
Timeframe: Baseline

Arms and interventions

Patients with genetically confirmed mitochondrial cytopathy who have undergone a muscle biopsy and d

In vitro experimentation and sample analysis

Control subjects having undergone orthopedic surgery resulting in discarded surgical tissue Or contr

In vitro experimentation and sample analysis

Other: Analysis of signaling pathway : AMPK

Sites

1 site in 1 country

  • Hôpital Neurologique de Lyon Pierre WertheimerBron, France